保利置業集團(00119.HK)擬6.7億元出售武漢長江保資控股100%權益
格隆匯 11 月 17日丨保利置業集團(00119.HK)宣佈,公司近日收到通知關於上海聯合產權交易所舉辦的公開投標流程出售由賣方湖北保利置業持有的目標公司武漢長江保資控股100%股權及相關債權,代價為人民幣6.70億元,其中包括目標公司於公佈日期欠賣方人民幣2245.25萬元。
公告稱,目標公司為賣方全資附屬公司,其主要資產位於中國武漢中南路99號的武漢保利文化廣場(一個綜合商業廣場)負1至8層及夾層1室。
預期出售事項將會提升集團資產週轉率併產生額外現金流入、提升集團收購或投資其他土地或房地產項目的能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.